INSP — Inspire Medical Systems Balance Sheet
0.000.00%
- $3.98bn
- $3.67bn
- $802.80m
- 87
- 21
- 51
- 53
Annual balance sheet for Inspire Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 234 | 214 | 451 | 460 | 446 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 25.1 | 34.2 | 61.2 | 89.9 | 93.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 270 | 269 | 530 | 594 | 631 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11.1 | 16.4 | 24.1 | 62.7 | 95.2 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 281 | 295 | 565 | 677 | 808 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20.7 | 41.3 | 61.2 | 78.1 | 88.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 51.4 | 66 | 68.9 | 104 | 119 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 230 | 229 | 496 | 573 | 690 |
| Total Liabilities & Shareholders' Equity | 281 | 295 | 565 | 677 | 808 |
| Total Common Shares Outstanding |